The true positives, true negatives, false positives, and false negatives are also useful in assessing the costs and benefits (or risks and gains) associated with a classification model. The cost associated with a false negative (such as incorrectly predicting that a cancerous patient is not cancerous) is far greater than those of a false positive (incorrectly yet conservatively labeling a noncancerous patient as cancerous). In such cases, we can outweigh one type of error over another by assigning a different cost to each. These costs may consider the danger to the patient, financial costs of resulting therapies, and other hospital costs. Similarly, the benefits associated with a true positive decision may be different than those of a true negative. Up to now, to compute classifier accuracy, we have assumed equal costs and essentially divided the sum of true positives and true negatives by the total number of test tuples.